MIST Milestone Pharmaceuticals Inc.: institutional ownership and insider trading
84 funds reported holding $68.2M of Milestone Pharmaceuticals Inc. in their latest 13F filings; in Q2 2026 funds net bought $14.4M, with 7 new positions and 13 funds selling out; over the last 12 months insiders bought $0 and sold $1.18M on the open market.
MIST revenue and earnings
- Quarter ended Jun 30, 2026: revenue $559K, net income −$28.6M, EPS -0.21
- Quarter ended Mar 31, 2026: revenue $238K, net income −$26.1M, EPS -0.20
- Quarter ended Dec 31, 2025: revenue n/a, net income $45.6M, EPS -0.12
- Quarter ended Sep 30, 2025: revenue n/a, net income −$11.9M, EPS -0.12
Famous investors holding MIST
- Izzy Englander (Millennium Management): $4.21M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $2.73M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $339K, 0.0% of the portfolio
Largest institutional holders of MIST
- Pavaki Capital Management LLC — $12.2M
- RTW INVESTMENTS, LP — $10.5M
- Propel Bio Management, LLC — $9.96M
- Point72 Asset Management, L.P. — $7.25M
- Simplify Asset Management Inc. — $4.49M
- MILLENNIUM MANAGEMENT LLC — $4.21M
- TWO SIGMA INVESTMENTS, LP — $2.73M
- MARSHALL WACE, LLP — $2.41M
- Kalehua Capital Management LLC — $1.70M
- Lion Point Capital, LP — $1.10M
Recent MIST insider trades
- Apr 16, 2026: Oliveto Joseph sold 36,500 shares ($82.5K)
- Jan 26, 2026: Hasija Amit sold 70,252 shares ($158K)
- Jan 26, 2026: Muller Lorenz sold 64,746 shares ($146K)
- Jan 26, 2026: Oliveto Joseph sold 167,577 shares ($375K)
5%+ owners
- RTW Investments, LP: 9.9% (Schedule 13G/A, filed May 15, 2026)
- Pavaki Capital Management LLC: 7.3% (Schedule 13G, filed Aug 7, 2026)
- Adage Capital Management, L.P.: 6.4% (Schedule 13G/A, filed May 13, 2026)
Who owns the most MIST stock?
The largest institutional holders of Milestone Pharmaceuticals Inc. in the latest 13F filings are Pavaki Capital Management LLC ($12.2M), RTW INVESTMENTS, LP ($10.5M), Propel Bio Management, LLC ($9.96M).
Are insiders buying or selling MIST?
Over the last 12 months insiders bought $0 and sold $1.18M of Milestone Pharmaceuticals Inc. stock on the open market (SEC Form 4).
Which famous investors own MIST?
Izzy Englander, Two Sigma, Ken Griffin.
What was MIST's revenue last quarter?
Milestone Pharmaceuticals Inc. reported revenue of $559K for the quarter ended June 30, 2026, with net income of −$28.6M.
Which ETFs hold MIST?
1 ETFs and mutual funds hold it among their top 100 positions, including SURI.